When Instadose was in the last stages of dying, and after Biocann was long dead - GNCP, after doing incredible due diligence, spent 150 million dollars in monopoly money acquiring Biocann based on non-existent revenues. Biocann had no business at the time or any assets. However GNCP affiliates were able to sell 4 billion shares that conveniently came of restriction at the time of the announcement.